Clinical Trial Results:
A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled
Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure.
Summary
|
|
EudraCT number |
2007-004271-19 |
Trial protocol |
HU IT DE FR GB ES NL |
Global completion date |
14 Aug 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Dec 2016
|
First version publication date |
15 Dec 2016
|
Other versions |
|
Summary report(s) |
CRLX.CHF.003_NovCTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.